Zydus Cadila offers ₹1,900 for its vaccine; talks are going on for slash price

Zydus Cadila offers ₹1,900 for its vaccine; talks are going on for slash price

.With talks underway between the central government and Zydus Cadila over the pricing of the Covid-19 vaccine ZyCov-D,

The pharma company studies to offer a price of ₹1,900 for a three-dose jab given to above 12 yrs of age.

However, the government is negotiating a price reduction, and a final decision is likely to be taken this week; people aware of the developments told PTI.

On Thursday, the government had said that the indigenously-developed, world’s first DNA-based needle-free COVID-19 vaccine by Zydus Cadila would be introduced in the nationwide anti-coronavirus vaccination drive shortly.

The people said.

“The company has proposed a price of ₹1,900 inclusive of taxes for its three-dose jab... Negotiations are on. The company has been asked to reconsider all the aspects regarding the cost of the vaccine. A final decision on the price of the vaccine is likely to be taken this week,”

Another person aware of the matter said the ZyCoV-D has to be different pricing than Covaxin and Covishield. Apart from being a three-dose vaccine, a needle-free jet injector is used to administer the vaccine costs ₹30,000.

The injector will be used for administering around 20,000 doses. The vaccine is to be given on days zero, 28, and 56.

Zydus Cadila offers 1900 for its vaccine talks are going on for slash price 1unsplash image

Read More: ZyCoV-D 2nd home vaccine to have vaccine drive soon

According to the people quoted above, around three rounds of meetings between Centre and company, the last one on Thursday.

Meanwhile, the ministry is also waiting for the recommendations from the National Technical Advisory Group on Immunisation (NTAGI )

To introduce ZyCoV-D in the vaccination drive and prioritize beneficiaries focusing on those aged 12-18 years with comorbidities.

Union health secretary Rajesh Bhushan said on Thursday that the government is in conversation with the manufacturers on the vaccine price.

He said.

“Since this is a three-dose vaccine and comes with a needleless delivery system, it would have a differential pricing than the existing vaccines which are being used in the Covid vaccination programme,”

ZyCoV-D received Emergency Use Authorisation from the drug regulator on August 20, making it the first vaccine to be administering in the age group of 12 to 18.

Follow Us

Popular Post

Maharashtra SSC Board Result 2022 To Be Announced Tomorrow

Maharashtra SSC Board Result 2022 To Be Announced Tomorrow

Farhan Sayyed Jun 16, 2022 Politics

The MSBSHSE (Maharashtra State Board of Secondary and Higher Secondary Education) will announce the SSC, Class 10 exam result 2022 on Friday, June 17...